Interventional Radiology

General Information

P.O. Box 208042, South Pavilion 2-213
New Haven, CT 06520-8042
Phone:
Fax:
203-785-4747
203-737-1077

 

Yale Interventional Radiology consists of a division of physicians specializing in the use of imaging modalities to guide the performance of minimally invasive diagnostic and therapeutic procedures in numerous parts of the body. Additionally, we are closely allied with Yale Vascular Surgery in a Yale Vascular Center, especially in the evaluation and treatment of arterial and venous blockages and aneurysms, including newer methods for angioplasty, the removal of material causing arterial blockage, and stent-grafts for aneurysms.


Clinical Interests

Other clinical interests include embolization for uterine fibroids, vascular anomalies, and pelvic congestion syndrome and varicoceles; minimally invasive treatment of cancer using embolization (including chemoembolization) and local treatments such as radiofrequency ablation; the management of varicose veins; interventions in bile ducts and the urinary track; and the placement of a variety of venous access devices.

Through the Yale Vascular Malformation Center, we are a world leader in the evaluation and treatment of patients with hereditary hemorrhagic telangiectasia (HHT, or Osler-Weber-Rendu syndrome).

Yale Interventional Radiologists see patients at our office in the Yale Physicians’ Building on Howard Avenue and perform procedures at Yale-New Haven Hospital and at the Veterans Administration Medical Center. In addition, we are active in training residents and fellows and conduct research.

Research Direction

  • Outcome of embolotherapy for pulmonary arteriovenous malformations
  • Transjugular intrahepatic portosystemic shunts
  • Locoregional therapy for hepatocellular carcinoma
  • Outcome after uterine fibroid embolization
  • Carotid artery stenosis
  • Thrombolytic spects and applications
  • CT angiography of peripheral vascular disease
  • Dynamic vascular imaging
  • Clinical applications of phase contrast imaging
  • Hemodialysis access catheters
  • Endovascular surgery
  • Stent technology
  • Vascular imaging: improving vascular outcomes
  • Fenestrated endografts; branched endografts
  • Embolotherapy technics
  • Vascular malformations
  • Male infertility
  • Pelvic congestion syndrome and fibroid disease
  • Hereditary Hemorrhagic Telangiectasia


Recent Publications

Levy EB, Krishnasamy VP, Lewis AL, Willis S, Macfarlane C, Anderson V, van der Bom IM, Radaelli A, Dreher MR, Sharma KV, Negussie A, Mikhail AS, Geschwind JF, Wood BJ: First Human Experience with Directly Image-able Iodinated Embolization Microbeads. Cardiovasc Intervent Radiol. 2016 Aug; 2016 May 20. PMID: 27206503

Kudo M, Lencioni R, Marrero JA, Venook AP, Bronowicki JP, Chen XP, Dagher L, Furuse J, Geschwind JF, Ladrón de Guevara L, Papandreou C, Sanyal AJ, Takayama T, Yoon SK, Nakajima K, Lehr R, Heldner S, Ye SL: Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study. Liver Int. 2016 Aug; 2016 Apr 1. PMID: 26901163

De Feyter HM, Behar KL, Rao JU, Madden-Hennessey K, Ip KL, Hyder F, Drewes LR, Geschwind JF, de Graaf RA, Rothman DL: A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth. Neuro Oncol. 2016 Aug; 2016 May 3. PMID: 27142056

Chapiro J, Geschwind JF: Science to Practice: Systemic Implications of Ablative Tumor Therapies-Reality Uncovered and Myths Exposed? Radiology. 2016 Aug. PMID: 27429140

Duran R, Mirpour S, Pekurovsky V, Ganapathy-Kanniappan S, Brayton CF, Cornish TC, Gorodetski B, Reyes J, Chapiro J, Schernthaner RE, Frangakis C, Lin M, Sun JD, Hart CP, Geschwind JF: Preclinical Benefit of Hypoxia-Activated Intraarterial Therapy with Evofosfamide in Liver Cancer. Clin Cancer Res. 2016 Jul 20; 2016 Jul 20. PMID: 27440271

Schernthaner RE, Haroun RR, Duran R, Lee H, Sahu S, Sohn JH, Chapiro J, Zhao Y, Gorodetski B, Fleckenstein F, Smolka S, Radaelli A, van der Bom IM, Lin M, Geschwind JF: Improved Visibility of Metastatic Disease in the Liver During Intra-Arterial Therapy Using Delayed Arterial Phase Cone-Beam CT. Cardiovasc Intervent Radiol. 2016 Jul 5; 2016 Jul 5. PMID: 27380872

Lencioni R, de Baere T, Soulen MC, Rilling WS, Geschwind JF: Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data. Hepatology. 2016 Jul; 2016 Mar 7. PMID: 26765068

Gorodetski B, Chapiro J, Schernthaner R, Duran R, Lin M, Lee H, Lenis D, Stuart EA, Nonyane BA, Pekurovsky V, Tamrazi A, Gebauer B, Schlachter T, Pawlik TM, Geschwind JF: Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization. Eur Radiol. 2016 Jun 8; 2016 Jun 8. PMID: 27277261

Dhir M, Melin AA, Douaiher J, Lin C, Zhen WK, Hussain SM, Geschwind JF, Doyle MB, Abou-Alfa GK, Are C: A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma. Ann Surg. 2016 Jun. PMID: 26813914

Wang Z, Hansis E, Chen R, Duran R, Chapiro J, Sheu YR, Kobeiter H, Grass M, Geschwind JF, Lin M: Automatic bone removal for 3D TACE planning with C-arm CBCT: Evaluation of technical feasibility. Minim Invasive Ther Allied Technol. 2016 Jun; 2016 Feb 29. PMID: 26923140

Tacher V, Duran R, Lin M, Sohn JH, Sharma KV, Wang Z, Chapiro J, Gacchina Johnson C, Bhagat N, Dreher MR, Schäfer D, Woods DL, Lewis AL, Tang Y, Grass M, Wood BJ, Geschwind JF: Multimodality Imaging of Ethiodized Oil-loaded Radiopaque Microspheres during Transarterial Embolization of Rabbits with VX2 Liver Tumors. Radiology. 2016 Jun; 2015 Dec 16. PMID: 26678453

Hickey R, Lewandowski RJ, Prudhomme T, Ehrenwald E, Baigorri B, Critchfield J, Kallini J, Gabr A, Gorodetski B, Geschwind JF, Abbott A, Shridhar R, White SB, Rilling WS, Boyer B, Kauffman S, Kwan S, Padia SA, Gates VL, Mulcahy M, Kircher S, Nimeiri H, Benson AB, Salem R: 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study. J Nucl Med. 2016 May; 2015 Dec 3. PMID: 26635340

Ayyagari RR, Yeh C, Arici M, Mojibian H, Reiner E, Pollak JS: Image-Guided Transvesicular Drainage of Pelvic Fluid Collections: A Safe and Effective Alternative Approach. J Vasc Interv Radiol. 2016 May. PMID: 27106643

Geschwind JF, Kudo M, Marrero JA, Venook AP, Chen XP, Bronowicki JP, Dagher L, Furuse J, Ladrón de Guevara L, Papandreou C, Sanyal AJ, Takayama T, Ye SL, Yoon SK, Nakajima K, Lehr R, Heldner S, Lencioni R: TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON. Radiology. 2016 May; 2016 Jan 8. PMID: 26744927

Chapiro J, Goldberg SN, Galun E, Geschwind JF: Response. Radiology. 2016 Apr. PMID: 27437552

de Baere T, Arai Y, Lencioni R, Geschwind JF, Rilling W, Salem R, Matsui O, Soulen MC: Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion. Cardiovasc Intervent Radiol. 2016 Mar; 2015 Sep 21. PMID: 26390875

Shalaby SY, Foster TR, Hall MR, Brownson KE, Vasilas P, Federman DG, Mojibian HR, Dardik A: Systemic Inflammatory Disease and Its Association With Type II Endoleak and Late Interventions After Endovascular Aneurysm Repair. JAMA Surg. 2016 Feb. PMID: 26501863

Geschwind JF, Gholam PM, Goldenberg A, Mantry P, Martin RC, Piperdi B, Zigmont E, Imperial J, Babajanyan S, Foreman PK, Cohn A: Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry. Liver Cancer. 2016 Feb; 2015 Dec 15. PMID: 26989658

Karthikeyan S, Potter JJ, Geschwind JF, Sur S, Hamilton JP, Vogelstein B, Kinzler KW, Mezey E, Ganapathy-Kanniappan S: Deregulation of energy metabolism promotes antifibrotic effects in human hepatic stellate cells and prevents liver fibrosis in a mouse model. Biochem Biophys Res Commun. 2016 Jan 15; 2015 Oct 23. PMID: 26525850

Gholamrezanezhad A, Mirpour S, Geschwind JH, Rao P, Loffroy R, Pellerin O, Liapi EA: Evaluation of 70-150-μm doxorubicin-eluting beads for transcatheter arterial chemoembolization in the rabbit liver VX2 tumour model. Eur Radiol. 2016 Jan 15; 2016 Jan 15. PMID: 26780638

Fleckenstein FN, Schernthaner RE, Duran R, Sohn JH, Sahu S, Zhao Y, Hamm B, Gebauer B, Lin M, Geschwind JF, Chapiro J: 3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival. Eur Radiol. 2016 Jan 13; 2016 Jan 13. PMID: 26762942

Ziganshin BA, Theodoropoulos P, Salloum MN, Zaza KJ, Tranquilli M, Mojibian HR, Dahl NK, Fang H, Rizzo JA, Elefteriades JA: Simple Renal Cysts as Markers of Thoracic Aortic Disease. J Am Heart Assoc. 2016 Jan 8; 2016 Jan 8. PMID: 26746998

Chockalingam A, Duran R, Sohn JH, Schernthaner R, Chapiro J, Lee H, Sahu S, Nguyen S, Geschwind JF, Lin M: Radiologic-pathologic analysis of quantitative 3D tumour enhancement on contrast-enhanced MR imaging: a study of ROI placement. Eur Radiol. 2016 Jan; 2015 May 21. PMID: 25994198

Savic LJ, Chapiro J, Duwe G, Geschwind JF: Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond? Hepat Oncol. 2016 Jan 1. PMID: 26989470

Tacher V, Lin M, Duran R, Yarmohammadi H, Lee H, Chapiro J, Chao M, Wang Z, Frangakis C, Sohn JH, Maltenfort MG, Pawlik T, Geschwind JF: Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach. Radiology. 2016 Jan; 2015 Jul 1. PMID: 26131913

Duran R, Sharma K, Dreher MR, Ashrafi K, Mirpour S, Lin M, Schernthaner RE, Schlachter TR, Tacher V, Lewis AL, Willis S, den Hartog M, Radaelli A, Negussie AH, Wood BJ, Geschwind JF: A Novel Inherently Radiopaque Bead for Transarterial Embolization to Treat Liver Cancer - A Pre-clinical Study. Theranostics. 2016; 2016 Jan 1. PMID: 26722371

Wang Z, Chen R, Duran R, Zhao Y, Yenokyan G, Chapiro J, Schernthaner R, Radaelli A, Lin M, Geschwind JF: Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma. Cardiovasc Intervent Radiol. 2015 Dec; 2015 May 23. PMID: 26001366

Schernthaner RE, Chapiro J, Sahu S, Withagen P, Duran R, Sohn JH, Radaelli A, van der Bom IM, Geschwind JF, Lin M: Feasibility of a Modified Cone-Beam CT Rotation Trajectory to Improve Liver Periphery Visualization during Transarterial Chemoembolization. Radiology. 2015 Dec; 2015 May 20. PMID: 26000642

Schernthaner RE, Duran R, Chapiro J, Wang Z, Geschwind JF, Lin M: A new angiographic imaging platform reduces radiation exposure for patients with liver cancer treated with transarterial chemoembolization. Eur Radiol. 2015 Nov; 2015 May 9. PMID: 25956933

Blenkinsop TA, Saini JS, Maminishkis A, Bharti K, Wan Q, Banzon T, Lotfi M, Davis J, Singh D, Rizzolo LJ, Miller S, Temple S, Stern JH: Human Adult Retinal Pigment Epithelial Stem Cell-Derived RPE Monolayers Exhibit Key Physiological Characteristics of Native Tissue. Invest Ophthalmol Vis Sci. 2015 Nov. PMID: 26540654

Cosgrove DP, Reyes DK, Pawlik TM, Feng AL, Kamel IR, Geschwind JF: Open-Label Single-Arm Phase II Trial of Sorafenib Therapy with Drug-eluting Bead Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma: Clinical Results. Radiology. 2015 Nov; 2015 Jun 11. PMID: 26069923

Quencer KB, Arici M: Arteriovenous Fistulas and Their Characteristic Sites of Stenosis. AJR Am J Roentgenol. 2015 Oct. PMID: 26397321

Geschwind JF: Locoregional therapy for patients with hepatocellular carcinoma. Clin Adv Hematol Oncol. 2015 Oct. PMID: 27058570

Geschwind JF: Locoregional Therapy for Patients With Hepatocellular Carcinoma. Gastroenterol Hepatol (N Y). 2015 Oct. PMID: 27330497

Savic LJ, Lin MD, Duran R, Schernthaner RE, Hamm B, Geschwind JF, Hong K, Chapiro J: Three-dimensional quantitative assessment of lesion response to MR-guided high-intensity focused ultrasound treatment of uterine fibroids. Acad Radiol. 2015 Sep; 2015 Jul 7. PMID: 26160057

Schernthaner RE, Lin M, Duran R, Chapiro J, Wang Z, Geschwind JF: Delayed-Phase Cone-Beam CT Improves Detectability of Intrahepatic Cholangiocarcinoma During Conventional Transarterial Chemoembolization. Cardiovasc Intervent Radiol. 2015 Aug; 2014 Dec 5. PMID: 25476872

Abou-Alfa GK, Geschwind JF, Choti M, d'Angelica MI: Consensus conference on intrahepatic cholangiocarcinoma. HPB (Oxford). 2015 Aug. PMID: 26172131

Chapiro J, Geschwind JF: Science to Practice: The Changing Face of Local Tumor Therapies-Do We Have to Think Systemically When Treating Cancer Locally? Radiology. 2015 Aug. PMID: 26203703

Wang Z, Chapiro J, Schernthaner R, Duran R, Chen R, Geschwind JF, Lin M: Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE. Acad Radiol. 2015 Jul; 2015 Apr 8. PMID: 25863795

Chapiro J, Duran R, Lin M, Schernthaner R, Lesage D, Wang Z, Savic LJ, Geschwind JF: Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver. Eur Radiol. 2015 Jul; 2015 Jan 31. PMID: 25636420

Lebastchi AH, Aruny JE, Donovan PI, Quinn CE, Callender GG, Carling T, Udelsman R: Real-Time Super Selective Venous Sampling in Remedial Parathyroid Surgery. J Am Coll Surg. 2015 Jun; 2015 Jan 22. PMID: 25868412

Courtney M, Ayyagari RR: Idiopathic chylopericardium treated by percutaneous thoracic duct embolization after failed surgical thoracic duct ligation. Pediatr Radiol. 2015 Jun; 2014 Sep 24. PMID: 25249390

Chapiro J, Duran R, Lin M, Werner JD, Wang Z, Schernthaner R, Savic LJ, Lessne ML, Geschwind JF, Hong K: Three-Dimensional Quantitative Assessment of Uterine Fibroid Response after Uterine Artery Embolization Using Contrast-Enhanced MR Imaging. J Vasc Interv Radiol. 2015 May; 2015 Jan 28. PMID: 25638750

Chapiro J, Duran R, Lin M, Schernthaner RE, Wang Z, Gorodetski B, Geschwind JF: Identifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non-three-dimensional Imaging Markers. Radiology. 2015 May; 2014 Dec 19. PMID: 25531387

Kunjithapatham R, Geschwind JF, Devine L, Boronina TN, O'Meally RN, Cole RN, Torbenson MS, Ganapathy-Kanniappan S: Occurrence of a multimeric high-molecular-weight glyceraldehyde-3-phosphate dehydrogenase in human serum. J Proteome Res. 2015 Apr 3; 2015 Mar 18. PMID: 25734908

Lee H, Chapiro J, Schernthaner R, Duran R, Wang Z, Gorodetski B, Geschwind JF, Lin M: How I do it: a practical database management system to assist clinical research teams with data collection, organization, and reporting. Acad Radiol. 2015 Apr; 2015 Jan 29. PMID: 25641319

Floridi C, Radaelli A, Abi-Jaoudeh N, Grass M, Lin M, Chiaradia M, Geschwind JF, Kobeiter H, Squillaci E, Maleux G, Giovagnoni A, Brunese L, Wood B, Carrafiello G, Rotondo A: Erratum to: C-arm cone-beam computed tomography in interventional oncology: technical aspects and clinical applications. Radiol Med. 2015 Apr. PMID: 25100305

Chapiro J, Duran R, Lin M, Mungo B, Schlachter T, Schernthaner R, Gorodetski B, Wang Z, Geschwind JF: Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver - the use of imaging biomarkers as predictors of patient survival. Eur J Radiol. 2015 Mar; 2014 Dec 13. PMID: 25542065

Fu D, Geschwind JF, Karthikeyan S, Miller E, Kunjithapatham R, Wang Z, Ganapathy-Kanniappan S: Metabolic perturbation sensitizes human breast cancer to NK cell-mediated cytotoxicity by increasing the expression of MHC class I chain-related A/B. Oncoimmunology. 2015 Mar; 2015 Jan 14. PMID: 25949910

Corona-Villalobos CP, Halappa VG, Geschwind JF, Bonekamp S, Reyes D, Cosgrove D, Pawlik TM, Kamel IR: Volumetric assessment of tumour response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib. Eur Radiol. 2015 Feb; 2014 Sep 17. PMID: 25226843

Chapiro J, Lin M, Duran R, Schernthaner RE, Geschwind JF: Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI. Expert Rev Anticancer Ther. 2015 Feb; 2014 Nov 5. PMID: 25371052

Tacher V, Radaelli A, Lin M, Geschwind JF: How I do it: Cone-beam CT during transarterial chemoembolization for liver cancer. Radiology. 2015 Feb. PMID: 25625741

Lafaro KJ, Cosgrove D, Geschwind JF, Kamel I, Herman JM, Pawlik TM: Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management. Gastroenterol Res Pract. 2015; 2015 May 19. PMID: 26089873

Geschwind JJ, Lin M: Cancer: see, reach, treat. Int Innov. 2015. PMID: 26617978

Chapiro J, Sur S, Savic LJ, Ganapathy-Kanniappan S, Reyes J, Duran R, Thiruganasambandam SC, Moats CR, Lin M, Luo W, Tran PT, Herman JM, Semenza GL, Ewald AJ, Vogelstein B, Geschwind JF: Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer. Clin Cancer Res. 2014 Dec 15; 2014 Oct 17. PMID: 25326230

Chapiro J, Wood LD, Lin M, Duran R, Cornish T, Lesage D, Charu V, Schernthaner R, Wang Z, Tacher V, Savic LJ, Kamel IR, Geschwind JF: Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis. Radiology. 2014 Dec; 2014 Jul 15. PMID: 25028783

Johnson DB, Flaherty KT, Weber JS, Infante JR, Kim KB, Kefford RF, Hamid O, Schuchter L, Cebon J, Sharfman WH, McWilliams RR, Sznol M, Lawrence DP, Gibney GT, Burris HA 3rd, Falchook GS, Algazi A, Lewis K, Long GV, Patel K, Ibrahim N, Sun P, Little S, Cunningham E, Sosman JA, Daud A, Gonzalez R: Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor. J Clin Oncol. 2014 Nov 20; 2014 Oct 6. PMID: 25287827

Ott PA, Hamid O, Pavlick AC, Kluger H, Kim KB, Boasberg PD, Simantov R, Crowley E, Green JA, Hawthorne T, Davis TA, Sznol M, Hwu P: Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with advanced melanoma. J Clin Oncol. 2014 Nov 10; 2014 Sep 29. PMID: 25267741

Bonekamp S, Bonekamp D, Geschwind JF, Corona-Villalobos CP, Reyes DK, Pawlik TM, Kamel IR: Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction. J Magn Reson Imaging. 2014 Nov; 2013 Nov 8. PMID: 24214827

Kunjithapatham R, Karthikeyan S, Geschwind JF, Kieserman E, Lin M, Fu DX, Ganapathy-Kanniappan S: Reversal of anchorage-independent multicellular spheroid into a monolayer mimics a metastatic model. Sci Rep. 2014 Oct 29; 2014 Oct 29. PMID: 25351825

Li L, Masica D, Ishida M, Tomuleasa C, Umegaki S, Kalloo AN, Georgiades C, Singh VK, Khashab M, Amateau S, Li Z, Okolo P, Lennon AM, Saxena P, Geschwind JF, Schlachter T, Hong K, Pawlik TM, Canto M, Law J, Sharaiha R, Weiss CR, Thuluvath P, Goggins M, Shin EJ, Peng H, Kumbhari V, Hutfless S, Zhou L, Mezey E, Meltzer SJ, Karchin R, Selaru FM: Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis. Hepatology. 2014 Sep; 2014 Jul 25. PMID: 24497320

Ganapathy-Kanniappan S, Karthikeyan S, Geschwind JF, Mezey E: Is the pathway of energy metabolism modified in advanced cirrhosis? J Hepatol. 2014 Aug; 2014 May 6. PMID: 24810232

Duran R, Chapiro J, Frangakis C, Lin M, Schlachter TR, Schernthaner RE, Wang Z, Savic LJ, Tacher V, Kamel IR, Geschwind JF: Uveal Melanoma Metastatic to the Liver: The Role of Quantitative Volumetric Contrast-Enhanced MR Imaging in the Assessment of Early Tumor Response after Transarterial Chemoembolization. Transl Oncol. 2014 Aug; 2014 Jun 20. PMID: 24953419

Floridi C, Radaelli A, Abi-Jaoudeh N, Grass M, Lin M, Chiaradia M, Geschwind JF, Kobeiter H, Squillaci E, Maleux G, Giovagnoni A, Brunese L, Wood B, Carrafiello G, Rotondo A: C-arm cone-beam computed tomography in interventional oncology: technical aspects and clinical applications. Radiol Med. 2014 Jul; 2014 Jul 11. PMID: 25012472

Chapiro J, Duran R, Geschwind JF: Combination of intra-arterial therapies and sorafenib: is there a clinical benefit? Radiol Med. 2014 Jul; 2014 Jun 4. PMID: 24894921

Chapiro J, Geschwind JF: Hepatocellular carcinoma: have we finally found the ultimate staging system for HCC? Nat Rev Gastroenterol Hepatol. 2014 Jun; 2014 May 6. PMID: 24798199

Karthikeyan S, Geschwind JF, Ganapathy-Kanniappan S: Tumor cells and memory T cells converge at glycolysis: therapeutic implications. Cancer Biol Ther. 2014 May; 2014 Feb 20. PMID: 24556820

Hogendoorn W, Schlösser FJ, Aruny JE, Indes JE, Sumpio BE, Muhs BE: Successful treatment of a proximal type I endoleak with HeliFX EndoAnchors. Ann Vasc Surg. 2014 Apr; 2013 Nov 1. PMID: 24184495

Wang Z, Lin M, Lesage D, Chen R, Chapiro J, Gu T, Tacher V, Duran R, Geschwind JF: Three-dimensional evaluation of lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCT. Acad Radiol. 2014 Mar. PMID: 24507426

Bonekamp D, Bonekamp S, Halappa VG, Geschwind JF, Eng J, Corona-Villalobos CP, Pawlik TM, Kamel IR: Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma. Eur J Radiol. 2014 Mar; 2013 Dec 3. PMID: 24387824

Cheng AL, Amarapurkar D, Chao Y, Chen PJ, Geschwind JF, Goh KL, Han KH, Kudo M, Lee HC, Lee RC, Lesmana LA, Lim HY, Paik SW, Poon RT, Tan CK, Tanwandee T, Teng G, Park JW: Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel. Liver Int. 2014 Feb; 2013 Nov 20. PMID: 24251922

Ganapathy-Kanniappan S, Geschwind JF: Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013 Dec 3; 2013 Dec 3. PMID: 24298908

Tacher V, Lin M, Bhagat N, Abi Jaoudeh N, Radaelli A, Noordhoek N, Carelsen B, Wood BJ, Geschwind JF: Dual-phase cone-beam computed tomography to see, reach, and treat hepatocellular carcinoma during drug-eluting beads transarterial chemo-embolization. J Vis Exp. 2013 Dec 2; 2013 Dec 2. PMID: 24326874

Chapiro J, Geschwind JF: Percutaneous therapies of hepatocellular carcinoma-an update. Chin Clin Oncol. 2013 Dec. PMID: 25841915

Dodson RM, Firoozmand A, Hyder O, Tacher V, Cosgrove DP, Bhagat N, Herman JM, Wolfgang CL, Geschwind JF, Kamel IR, Pawlik TM: Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies. J Gastrointest Surg. 2013 Dec; 2013 Sep 25. PMID: 24065364

Chen R, Geschwind JF, Wang Z, Tacher V, Lin M: Quantitative assessment of lipiodol deposition after chemoembolization: comparison between cone-beam CT and multidetector CT. J Vasc Interv Radiol. 2013 Dec; 2013 Oct 1. PMID: 24094672

Hyder O, Marsh JW, Salem R, Petre EN, Kalva S, Liapi E, Cosgrove D, Neal D, Kamel I, Zhu AX, Sofocleous CT, Geschwind JF, Pawlik TM: Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis. Ann Surg Oncol. 2013 Nov; 2013 Jul 12. PMID: 23846786

Hyder O, Dodson RM, Nathan H, Herman JM, Cosgrove D, Kamel I, Geschwind JF, Pawlik TM: Referral patterns and treatment choices for patients with hepatocellular carcinoma: a United States population-based study. J Am Coll Surg. 2013 Nov; 2013 Sep 13. PMID: 24041557

Bari K, Aslanian HR, Pollak J, Reiner E, Salem RR, Taddei TH, Emre SH, Jamidar PA: Emphysematous Cholecystitis Resulting in Secondary Biliary Cirrhosis: A Rare Complication of Endoscopic Retrograde Cholangiopancreatography. ACG Case Rep J. 2013 Oct; 2013 Oct 8. PMID: 26157820

Benson AB 3rd, Geschwind JF, Mulcahy MF, Rilling W, Siskin G, Wiseman G, Cunningham J, Houghton B, Ross M, Memon K, Andrews J, Fleming CJ, Herman J, Nimeiri H, Lewandowski RJ, Salem R: Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study. Eur J Cancer. 2013 Oct; 2013 Jun 15. PMID: 23777743

Chapiro J, Tacher V, Geschwind JF: Intraarterial therapies for primary liver cancer: state of the art. Expert Rev Anticancer Ther. 2013 Oct; 2013 Oct 7. PMID: 24099626

Dodson RM, Weiss MJ, Cosgrove D, Herman JM, Kamel I, Anders R, Geschwind JF, Pawlik TM: Intrahepatic cholangiocarcinoma: management options and emerging therapies. J Am Coll Surg. 2013 Oct; 2013 Jul 24. PMID: 23890842

Hyder O, Dodson RM, Weiss M, Cosgrove DP, Herman JM, Geschwind JF, Kamel IR, Pawlik TM: Trends and patterns of utilization in post-treatment surveillance imaging among patients treated for hepatocellular carcinoma. J Gastrointest Surg. 2013 Oct; 2013 Aug 14. PMID: 23943387

Stacy S, Hyder O, Cosgrove D, Herman JM, Kamel I, Geschwind JF, Gurakar A, Anders R, Cameron A, Pawlik TM: Patterns of consultation and treatment of patients with hepatocellular carcinoma presenting to a large academic medical center in the US. J Gastrointest Surg. 2013 Sep; 2013 Jun 19. PMID: 23780638

Tacher V, Bhagat N, Rao PV, Lin M, Schäfer D, Noordhoek N, Eshuis P, Radaelli A, Liapi E, Grass M, Geschwind JF: Image quality improvements in C-Arm CT (CACT) for liver oncology applications: preliminary study in rabbits. Minim Invasive Ther Allied Technol. 2013 Sep; 2013 Jul 9. PMID: 23837536

Bonekamp S, Halappa VG, Geschwind JF, Li Z, Corona-Villalobos CP, Reyes D, Bhagat N, Cosgrove DP, Pawlik TM, Mezey E, Eng J, Kamel IR: Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy. Radiology. 2013 Aug; 2013 Apr 24. PMID: 23616632

Bonekamp S, Li Z, Geschwind JF, Halappa VG, Corona-Villalobos CP, Reyes D, Pawlik TM, Bonekamp D, Eng J, Kamel IR: Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria. Radiology. 2013 Aug; 2013 Apr 24. PMID: 23616631

Kunjithapatham R, Geschwind JF, Rao PP, Boronina TN, Cole RN, Ganapathy-Kanniappan S: Systemic administration of 3-bromopyruvate reveals its interaction with serum proteins in a rat model. BMC Res Notes. 2013 Jul 17; 2013 Jul 17. PMID: 23866825

Pellerin O, Lin M, Bhagat N, Shao W, Geschwind JF: Can C-arm cone-beam CT detect a micro-embolic effect after TheraSphere radioembolization of neuroendocrine and carcinoid liver metastasis? Cancer Biother Radiopharm. 2013 Jul-Aug. PMID: 23484809

Young LH, Henderson KJ, White RI, Garcia-Tsao G: Bevacizumab: finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary hemorrhagic telangiectasia. Hepatology. 2013 Jul; 2013 May 31. PMID: 23686865

Pollak JS: Consider the perspectives: interventional radiology. J Clin Gastroenterol. 2013 Jul. PMID: 23632350

Ota S, Geschwind JF, Buijs M, Wijlemans JW, Kwak BK, Ganapathy-Kanniappan S: Ultrasound-guided direct delivery of 3-bromopyruvate blocks tumor progression in an orthotopic mouse model of human pancreatic cancer. Target Oncol. 2013 Jun; 2013 Mar 26. PMID: 23529644

Buijs M, Wijlemans JW, Kwak BK, Ota S, Geschwind JF: Antiglycolytic therapy combined with an image-guided minimally invasive delivery strategy for the treatment of breast cancer. J Vasc Interv Radiol. 2013 May; 2013 Mar 13. PMID: 23489770

Tacher V, Lin M, Chao M, Gjesteby L, Bhagat N, Mahammedi A, Ardon R, Mory B, Geschwind JF: Semiautomatic volumetric tumor segmentation for hepatocellular carcinoma: comparison between C-arm cone beam computed tomography and MRI. Acad Radiol. 2013 Apr. PMID: 23498985

Buijs M, Reyes DK, Pawlik TM, Blackford AL, Salem R, Messersmith WA, Weekes CD, Mulcahy M, Kamel IR, Geschwind JF: Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. Cancer. 2013 Mar 1; 2012 Nov 6. PMID: 23132335

Brown HA, Aruny JE, Elefteriades JA, Sumpio BE: Subclavian aneurysm presenting with massive hemoptysis: a case report and review of the literature. Int J Angiol. 2013 Mar. PMID: 24436588

Park JW, Amarapurkar D, Chao Y, Chen PJ, Geschwind JF, Goh KL, Han KH, Kudo M, Lee HC, Lee RC, Lesmana LA, Lim HY, Paik SW, Poon RT, Tan CK, Tanwandee T, Teng G, Cheng AL: Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC). Liver Int. 2013 Mar; 2013 Jan 18. PMID: 23331661

Ganapathy-Kanniappan S, Kunjithapatham R, Geschwind JF: Statins impair glucose uptake in tumor cells. Cancer Biol Ther. 2013 Feb; 2012 Dec 19. PMID: 23254955

Gowdra Halappa V, Corona-Villalobos CP, Bonekamp S, Li Z, Reyes D, Cosgrove D, Pawlik TM, Diaz LA, Bhagat N, Eng J, Geschwind JF, Kamel IR: Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survival. Radiology. 2013 Feb; 2012 Nov 28. PMID: 23192780

Loffroy R, Lin M, Yenokyan G, Rao PP, Bhagat N, Noordhoek N, Radaelli A, Blijd J, Liapi E, Geschwind JF: Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma? Radiology. 2013 Feb; 2012 Nov 9. PMID: 23143027

Pellerin O, Lin M, Bhagat N, Ardon R, Mory B, Geschwind JF: Comparison of semi-automatic volumetric VX2 hepatic tumor segmentation from cone beam CT and multi-detector CT with histology in rabbit models. Acad Radiol. 2013 Jan; 2012 Sep 2. PMID: 22947274

Ganapathy-Kanniappan S, Kunjithapatham R, Geschwind JF: Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting. Anticancer Res. 2013 Jan. PMID: 23267123

Mayo SC, Herman JM, Cosgrove D, Bhagat N, Kamel I, Geschwind JF, Pawlik TM: Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies. J Am Coll Surg. 2013 Jan; 2012 Oct 11. PMID: 23063263

Buijs M, Geschwind JF, Syed LH, Ganapathy-Kanniappan S, Kunjithapatham R, Wijlemans JW, Kook Kwak B, Ota S, Vali M: Spontaneous tumor regression in a syngeneic rat model of liver cancer: implications for survival studies. J Vasc Interv Radiol. 2012 Dec. PMID: 23177115

Lin M, Pellerin O, Bhagat N, Rao PP, Loffroy R, Ardon R, Mory B, Reyes DK, Geschwind JF: Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembolization. J Vasc Interv Radiol. 2012 Dec. PMID: 23177109

Pollak JS, White RI Jr: Distal cross-sectional occlusion is the "key" to treating pulmonary arteriovenous malformations. J Vasc Interv Radiol. 2012 Dec. PMID: 23177104

Nishida T, Faughnan ME, Krings T, Chakinala M, Gossage JR, Young WL, Kim H, Pourmohamad T, Henderson KJ, Schrum SD, James M, Quinnine N, Bharatha A, Terbrugge KG, White RI Jr: Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene-phenotype correlations. Am J Med Genet A. 2012 Nov; 2012 Sep 18. PMID: 22991266

Liapi E, Geschwind JF: Combination of local transcatheter arterial chemoembolization and systemic anti-angiogenic therapy for unresectable hepatocellular carcinoma. Liver Cancer. 2012 Nov. PMID: 24159585

Kneuertz PJ, Malla M, Cosgrove DP, Herman JM, Kamel IR, Geschwind JF, Cameron AM, Pawlik TM: Image of the month. Recurrent metastatic HCC. Arch Surg. 2012 Oct. PMID: 23070415

Kneuertz PJ, Malla M, Cosgrove DP, Herman JM, Kamel IR, Geschwind JF, Cameron AM, Pawlik TM: Image of the month-quiz case. Arch Surg. 2012 Oct 1. PMID: 24901513

Lencioni R, de Baere T, Burrel M, Caridi JG, Lammer J, Malagari K, Martin RC, O'Grady E, Real MI, Vogl TJ, Watkinson A, Geschwind JF: Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations. Cardiovasc Intervent Radiol. 2012 Oct; 2011 Oct 19. PMID: 22009576

Georgiades C, Geschwind JF, Harrison N, Hines-Peralta A, Liapi E, Hong K, Wu Z, Kamel I, Frangakis C: Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment? Radiology. 2012 Oct; 2012 Aug 13. PMID: 22891361

Kneuertz PJ, Demirjian A, Firoozmand A, Corona-Villalobos C, Bhagat N, Herman J, Cameron A, Gurakar A, Cosgrove D, Choti MA, Geschwind JF, Kamel IR, Pawlik TM: Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes. Ann Surg Oncol. 2012 Sep; 2012 Apr 3. PMID: 22476754

Ganapathy-Kanniappan S, Kunjithapatham R, Geschwind JF: Glyceraldehyde-3-phosphate dehydrogenase: a promising target for molecular therapy in hepatocellular carcinoma. Oncotarget. 2012 Sep. PMID: 22964488

Peng PD, Hyder O, Bloomston M, Marques H, Corona-Villalobos C, Dixon E, Pulitano C, Hirose K, Schulick RD, Barroso E, Aldrighetti L, Choti M, Shen F, Kamel I, Geschwind JF, Pawlik TM: Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignancies. HPB (Oxford). 2012 Aug; 2012 May 31. PMID: 22762400

Halappa VG, Bonekamp S, Corona-Villalobos CP, Li Z, Mensa M, Reyes D, Eng J, Bhagat N, Pawlik TM, Geschwind JF, Kamel IR: Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response. Radiology. 2012 Jul; 2012 May 24. PMID: 22627601

Kneuertz PJ, Cosgrove DP, Cameron AM, Kamel IR, Geschwind JF, Herman JM, Pawlik TM: Multidisciplinary management of recurrent hepatocellular carcinoma following liver transplantation. J Gastrointest Surg. 2012 Apr. PMID: 21975686

Kaoukis A, Panagopoulou V, Mojibian HR, Jacoby D: Reverse Takotsubo cardiomyopathy associated with the consumption of an energy drink. Circulation. 2012 Mar 27. PMID: 22451608

Ganapathy-Kanniappan S, Kunjithapatham R, Torbenson MS, Rao PP, Carson KA, Buijs M, Vali M, Geschwind JF: Human hepatocellular carcinoma in a mouse model: assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists. Radiology. 2012 Mar. PMID: 22357885

Loffroy R, Lin M, Rao P, Bhagat N, Noordhoek N, Radaelli A, Blijd J, Geschwind JF: Comparing the detectability of hepatocellular carcinoma by C-arm dual-phase cone-beam computed tomography during hepatic arteriography with conventional contrast-enhanced magnetic resonance imaging. Cardiovasc Intervent Radiol. 2012 Feb; 2011 Feb 17. PMID: 21328023

Assis DN, Pollak J, Schilsky ML, Emre S: Successful treatment of a bleeding umbilical varix by percutaneous umbilical vein embolization with sclerotherapy. J Clin Gastroenterol. 2012 Feb. PMID: 21897280

Janne d'Othée B, Sofocleous CT, Hanna N, Lewandowski RJ, Soulen MC, Vauthey JN, Cohen SJ, Venook AP, Johnson MS, Kennedy AS, Murthy R, Geschwind JF, Kee ST: Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol. 2012 Feb. PMID: 22264550

Basco MT, Schlösser FJ, Muhs BE, Indes JE, Blume PA, Key JJ, Aruny JE, Sumpio BE: Lower extremity limb salvage with cryoplasty: a single-center cohort study. Vascular. 2012 Feb; 2012 Feb 10. PMID: 22328618

Mayo SC, de Jong MC, Bloomston M, Pulitano C, Clary BM, Reddy SK, Clark Gamblin T, Celinski SA, Kooby DA, Staley CA, Stokes JB, Chu CK, Arrese D, Ferrero A, Schulick RD, Choti MA, Geschwind JF, Strub J, Bauer TW, Adams RB, Aldrighetti L, Mentha G, Capussotti L, Pawlik TM: Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Ann Surg Oncol. 2011 Dec; 2011 Jun 17. PMID: 21681380

Frangakis C, Geschwind JF, Kim D, Chen Y, Koteish A, Hong K, Liapi E, Georgiades CS: Chemoembolization decreases drop-off risk of hepatocellular carcinoma patients on the liver transplant list. Cardiovasc Intervent Radiol. 2011 Dec; 2010 Dec 30. PMID: 21191590

Ray CE Jr, Haskal ZJ, Geschwind JF, Funaki BS: The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a response to the Cochrane Collaboration review of 2011. J Vasc Interv Radiol. 2011 Dec; 2011 Oct 27. PMID: 22035882

Demirjian A, Peng P, Geschwind JF, Cosgrove D, Schutz J, Kamel IR, Pawlik TM: Infiltrating hepatocellular carcinoma: seeing the tree through the forest. J Gastrointest Surg. 2011 Nov; 2011 Jul 2. PMID: 21725699

Pawlik TM, Reyes DK, Cosgrove D, Kamel IR, Bhagat N, Geschwind JF: Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. J Clin Oncol. 2011 Oct 20; 2011 Sep 12. PMID: 21911714

Lin M, Loffroy R, Noordhoek N, Taguchi K, Radaelli A, Blijd J, Balguid A, Geschwind JF: Evaluating tumors in transcatheter arterial chemoembolization (TACE) using dual-phase cone-beam CT. Minim Invasive Ther Allied Technol. 2011 Sep; 2010 Nov 17. PMID: 21082901

Buijs M, Vossen JA, Geschwind JF, Salibi N, Pan L, Ventura VP, Liapi E, Lee KH, Kamel IR: Quantitative proton MR spectroscopy as a biomarker of tumor necrosis in the rabbit VX2 liver tumor. J Vasc Interv Radiol. 2011 Aug; 2011 May 28. PMID: 21620723

Liapi E, Geschwind JF: Medium-sized HCC: achieving effective local tumor control with combined chemoebolization and radiofrequency ablation. Ann Surg Oncol. 2011 Jun. PMID: 21431403

Bonekamp D, Reyes DK, Bonekamp S, Wahlin TA, Geschwind JF, Fishman EK, Kamel IR: Complications of loco-regional therapy in the liver-spectrum of imaging findings by CT and MRI. Emerg Radiol. 2011 Jun; 2011 Feb 16. PMID: 21327446

Lewandowski RJ, Geschwind JF, Liapi E, Salem R: Transcatheter intraarterial therapies: rationale and overview. Radiology. 2011 Jun. PMID: 21602502

Schlösser FJ, Aruny JE, Freiburg CB, Mojibian HR, Sumpio BE, Muhs BE: The chimney procedure is an emergently available endovascular solution for visceral aortic aneurysm rupture. J Vasc Surg. 2011 May; 2011 Jan 26. PMID: 21276684

Loffroy R, Gergele F, Rao P, Geschwind JF: Endovascular management of a posttraumatic pseudoaneurysm of the common carotid artery with superselective coil embolization. J Vasc Surg. 2011 Apr; 2010 May 26. PMID: 20510566

Bonekamp S, Shen J, Salibi N, Lai HC, Geschwind J, Kamel IR: Early response of hepatic malignancies to locoregional therapy-value of diffusion-weighted magnetic resonance imaging and proton magnetic resonance spectroscopy. J Comput Assist Tomogr. 2011 Mar-Apr. PMID: 21412085

Salem R, Lewandowski RJ, Gates VL, Nutting CW, Murthy R, Rose SC, Soulen MC, Geschwind JF, Kulik L, Kim YH, Spreafico C, Maccauro M, Bester L, Brown DB, Ryu RK, Sze DY, Rilling WS, Sato KT, Sangro B, Bilbao JI, Jakobs TF, Ezziddin S, Kulkarni S, Kulkarni A, Liu DM, Valenti D, Hilgard P, Antoch G, Muller SP, Alsuhaibani H, Mulcahy MF, Burrel M, Real MI, Spies S, Esmail AA, Raoul JL, Garin E, Johnson MS, Benson AB 3rd, Sharma RA, Wasan H, Lambert B, Memon K, Kennedy AS, Riaz A, Technology Assessment Committee, Interventional Oncology Task Force of the Society of Interventional Radiology: Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol. 2011 Mar. PMID: 21353979

Liapi E, Geschwind JF: Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization? Cardiovasc Intervent Radiol. 2011 Feb; 2010 Nov 12. PMID: 21069333

Ni N, Mojibian H, Pollak J, Tal M: Association between disruption of fibrin sheaths using percutaneous transluminal angioplasty balloons and late onset of central venous stenosis. Cardiovasc Intervent Radiol. 2011 Feb; 2010 May 4. PMID: 20440497

Liapi E, Geschwind JF, Vali M, Khwaja AA, Prieto-Ventura V, Buijs M, Vossen JA, Ganapathy-Kanniappan S, Wahl RL: Assessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor. J Nucl Med. 2011 Feb; 2011 Jan 13. PMID: 21233194

Loffroy R, Rao P, Kwak BK, Geschwind JF: Letter to the Editor re: superselective arterial embolisation with a liquid polyvinyl alcohol copolymer in patients with acute gastrointestinal haemorrhage. Eur Radiol. 2011 Jan; 2010 Jul 31. PMID: 20676651

Loffroy R, Rao P, Ota S, De Lin M, Kwak BK, Geschwind JF: Embolization of acute nonvariceal upper gastrointestinal hemorrhage resistant to endoscopic treatment: results and predictors of recurrent bleeding. Cardiovasc Intervent Radiol. 2010 Dec; 2010 Mar 16. PMID: 20232200

Mojibian HR, Oneal P, Eliseo D, Tal MG: VenaTrac™ device for over-the-wire placement of chronic dialysis catheters. J Vasc Access. 2010 Oct-Dec. PMID: 20853251

De Jong MC, Farnell MB, Sclabas G, Cunningham SC, Cameron JL, Geschwind JF, Wolfgang CL, Herman JM, Edil BH, Choti MA, Schulick RD, Nagorney DM, Pawlik TM: Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis. Ann Surg. 2010 Jul. PMID: 20531007

Liapi E, Geschwind JF: Interventional oncology: new options for interstitial treatments and intravascular approaches: targeting tumor metabolism via a loco-regional approach: a new therapy against liver cancer. J Hepatobiliary Pancreat Sci. 2010 Jul; 2009 Nov 5. PMID: 19890602

Lee KH, Liapi EA, Cornell C, Reb P, Buijs M, Vossen JA, Ventura VP, Geschwind JF: Doxorubicin-loaded QuadraSphere microspheres: plasma pharmacokinetics and intratumoral drug concentration in an animal model of liver cancer. Cardiovasc Intervent Radiol. 2010 Jun; 2010 Jan 20. PMID: 20087738

Liapi E, Geschwind JF: Intra-arterial therapies for hepatocellular carcinoma: where do we stand? Ann Surg Oncol. 2010 May; 2010 Apr 20. PMID: 20405328

Loffroy R, Rao P, Kwak BK, Ota S, De Lin M, Liapi E, Geschwind JF: Transcatheter arterial embolization in patients with kidney diseases: an overview of the technical aspects and clinical indications. Korean J Radiol. 2010 May-Jun; 2010 Apr 29. PMID: 20461179

Ganapathy-Kanniappan S, Geschwind JF, Kunjithapatham R, Buijs M, Syed LH, Rao PP, Ota S, Vali M: The pyruvic acid analog 3-bromopyruvate interferes with the tetrazolium reagent MTS in the evaluation of cytotoxicity. Assay Drug Dev Technol. 2010 Apr. PMID: 20085459

Golzarian J, Sapoval MR, Kundu S, Hunter DW, Brountzos EN, Geschwind JF, Murphy TP, Spies JB, Wallace MJ, de Baere T, Cardella JF, Society of Interventional Radiology (SIR), Cardiovascular and Interventional Radiological Society of Europe (CIRSE), Canadian Interventional Radiology Association (CIRA): Guidelines for Peripheral and Visceral Vascular Embolization Training: joint writing groups of the Standards of Practice Committees for the Society of Interventional Radiology (SIR), Cardiovascular and Interventional Radiological Society of Europe (CIRSE), and Canadian Interventional Radiology Association (CIRA). J Vasc Interv Radiol. 2010 Apr. PMID: 20346881

Hong K, Geschwind JF: Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma. Semin Oncol. 2010 Apr. PMID: 20494703

Ganapathy-Kanniappan S, Geschwind JF, Kunjithapatham R, Buijs M, Syed LH, Rao PP, Ota S, Kwak BK, Loffroy R, Vali M: 3-Bromopyruvate induces endoplasmic reticulum stress, overcomes autophagy and causes apoptosis in human HCC cell lines. Anticancer Res. 2010 Mar. PMID: 20393016

Liapi E, Geschwind JF: Chemoembolization for primary and metastatic liver cancer. Cancer J. 2010 Mar-Apr. PMID: 20404613

Saad A, Pollak J, Dardik A: Images in vascular medicine: asymptomatic internal carotid artery stent fracture. Vasc Med. 2010 Feb; 2009 Sep 24. PMID: 19778952

Grimm LJ, Cornfeld D, Mojibian HR: The effect of left-sided versus right-sided contrast infusion on attenuation of the main pulmonary artery when performing computed tomography angiograms of the chest. J Comput Assist Tomogr. 2010 Jan. PMID: 20118722

Ye SL, Takayama T, Geschwind J, Marrero JA, Bronowicki JP: Current approaches to the treatment of early hepatocellular carcinoma. Oncologist. 2010. PMID: 21115579

Ganapathy-Kanniappan S, Geschwind JF, Kunjithapatham R, Buijs M, Vossen JA, Tchernyshyov I, Cole RN, Syed LH, Rao PP, Ota S, Vali M: Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death. Anticancer Res. 2009 Dec. PMID: 20044597

Reyes DK, Vossen JA, Kamel IR, Azad NS, Wahlin TA, Torbenson MS, Choti MA, Geschwind JF: Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J. 2009 Nov-Dec. PMID: 20010173

Mojibian H, Spector M, Ni N, Eliseo D, Pollak J, Tal M: Initial clinical experience with a new heparin-coated chronic hemodialysis catheter. Hemodial Int. 2009 Jul; 2009 May 15. PMID: 19473278

Vossen JA, Buijs M, Geschwind JF, Liapi E, Prieto Ventura V, Lee KH, Bluemke DA, Kamel IR: Diffusion-weighted and Gd-EOB-DTPA-contrast-enhanced magnetic resonance imaging for characterization of tumor necrosis in an animal model. J Comput Assist Tomogr. 2009 Jul-Aug. PMID: 19638862

Lee KH, Liapi E, Buijs M, Vossen JA, Prieto-Ventura V, Syed LH, Geschwind JF: Percutaneous US-guided implantation of Vx-2 carcinoma into rabbit liver: a comparison with open surgical method. J Surg Res. 2009 Jul; 2008 Sep 29. PMID: 19181344

Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, Rilling WS, Geschwind JF, Salem R, Vedantham S, Cardella JF, Soulen MC, Society of Interventional Radiology Technology Assessment Committee and the International Working Group on Image-Guided Tumor Ablation: Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2009 Jul. PMID: 19560030

Brown DB, Geschwind JF, Soulen MC, Millward SF, Sacks D: Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol. 2009 Jul. PMID: 19560017

Moukaddam H, Pollak J, Haims AH: MRI characteristics and classification of peripheral vascular malformations and tumors. Skeletal Radiol. 2009 Jun; 2008 Nov 20. PMID: 19020874

Buijs M, Vossen JA, Geschwind JF, Ishimori T, Engles JM, Acha-Ngwodo O, Wahl RL, Vali M: Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer. Invest New Drugs. 2009 Apr; 2008 Jun 14. PMID: 18553054

Jain A, Smith C, Geschwind JF, Pawlik TM: Image of the month. Gastrohepatic fistula following TACE for HCC. Arch Surg. 2009 Mar. PMID: 19289671

Hong K, McBride JD, Georgiades CS, Reyes DK, Herman JM, Kamel IR, Geschwind JF: Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. J Vasc Interv Radiol. 2009 Mar; 2009 Jan 23. PMID: 19167245

Taguchi K, Funama Y, Zhang M, Fishman EK, Geschwind JF: Quantitative measurement of iodine concentration in the liver using abdominal C-arm computed tomography. Acad Radiol. 2009 Feb. PMID: 19124106

Abramowitz SD, Israel GM, McCarthy SM, Pollak JS, White RI Jr, Tal MG: Comparison of four embolic materials at uterine artery embolization by using postprocedural MR imaging enhancement. Radiology. 2009 Feb. PMID: 19188316

Kamel IR, Liapi E, Reyes DK, Zahurak M, Bluemke DA, Geschwind JF: Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology. 2009 Feb. PMID: 19188315

Lee KH, Liapi E, Buijs M, Vossen J, Hong K, Georgiades C, Geschwind JF: Considerations for implantation site of VX2 carcinoma into rabbit liver. J Vasc Interv Radiol. 2009 Jan; 2008 Nov 22. PMID: 19028118

Assumpcao L, Cameron JL, Wolfgang CL, Edil B, Choti MA, Herman JM, Geschwind JF, Hong K, Georgiades C, Schulick RD, Pawlik TM: Incidence and management of chyle leaks following pancreatic resection: a high volume single-center institutional experience. J Gastrointest Surg. 2008 Nov; 2008 Aug 7. PMID: 18685899

Vali M, Vossen JA, Buijs M, Engles JM, Liapi E, Ventura VP, Khwaja A, Acha-Ngwodo O, Ganapathy-Kanniappan S, Syed L, Wahl RL, Geschwind JF: Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study. J Pharmacol Exp Ther. 2008 Oct; 2008 Jun 30. PMID: 18591216

Lee KH, Liapi E, Vossen JA, Buijs M, Ventura VP, Georgiades C, Hong K, Kamel I, Torbenson MS, Geschwind JF: Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy. J Vasc Interv Radiol. 2008 Oct; 2008 Aug 27. PMID: 18755602

Buijs M, Vossen JA, Frangakis C, Hong K, Georgiades CS, Chen Y, Liapi E, Geschwind JF: Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization--single-center experience. Radiology. 2008 Oct. PMID: 18796686

El-Khouli RH, Geschwind JF, Bluemke DA, Kamel IR: Solitary fibrous tumor of the liver: magnetic resonance imaging evaluation and treatment with transarterial chemoembolization. J Comput Assist Tomogr. 2008 Sep-Oct. PMID: 18830108

Georgiades CS, Hong K, Bizzell C, Geschwind JF, Rodriguez R: Safety and efficacy of CT-guided percutaneous cryoablation for renal cell carcinoma. J Vasc Interv Radiol. 2008 Sep; 2008 Jul 11. PMID: 18725093

Schlösser FJ, Mojibian HR, Dardik A, Verhagen HJ, Moll FL, Muhs BE: Simultaneous sizing and preoperative risk stratification for thoracic endovascular aneurysm repair: role of gated computed tomography. J Vasc Surg. 2008 Sep; 2008 Jun 30. PMID: 18586438

Spector M, Pollak JS: Management of malignant pleural effusions. Semin Respir Crit Care Med. 2008 Aug. PMID: 18651358

Buijs M, Vossen JA, Hong K, Georgiades CS, Geschwind JF, Kamel IR: Chemoembolization of hepatic metastases from ocular melanoma: assessment of response with contrast-enhanced and diffusion-weighted MRI. AJR Am J Roentgenol. 2008 Jul. PMID: 18562760

Lee KH, Liapi E, Ventura VP, Buijs M, Vossen JA, Vali M, Geschwind JF: Evaluation of different calibrated spherical polyvinyl alcohol microspheres in transcatheter arterial chemoembolization: VX2 tumor model in rabbit liver. J Vasc Interv Radiol. 2008 Jul; 2008 Apr 10. PMID: 18589321

Levine CG, Ross DA, Henderson KJ, Leder SB, White RI Jr: Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg. 2008 Jun. PMID: 18503842

Galvez JA, McCarthy S, Weinreb J, Zelterman D, White RI, Pollak J, Tal MG: Comparison of MRI outcomes of uterine artery embolization for uterine leiomyoma using tris-acryl gelatin microspheres, polyvinyl alcohol spheres, and polyvinyl alcohol particles. J Comput Assist Tomogr. 2008 May-Jun. PMID: 18520537

Vossen JA, Kamel IR, Buijs M, Liapi E, Georgiades CS, Hong K, Geschwind JF: Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization. J Comput Assist Tomogr. 2008 May-Jun. PMID: 18520535

Georgiades CS, Hong K, Geschwind JF: Radiofrequency ablation and chemoembolization for hepatocellular carcinoma. Cancer J. 2008 Mar-Apr. PMID: 18391617

Reiner E, Pollak JS, Henderson KJ, Weiss RM, White RI Jr: Initial experience with 3% sodium tetradecyl sulfate foam and fibered coils for management of adolescent varicocele. J Vasc Interv Radiol. 2008 Feb. PMID: 18341950

Liapi E, Geschwind JF, Vossen JA, Buijs M, Georgiades CS, Bluemke DA, Kamel IR: Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. AJR Am J Roentgenol. 2008 Jan. PMID: 18094295

Vossen JA, Buijs M, Syed L, Kutiyanwala F, Kutiyanwala M, Geschwind JF, Vali M: Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization. Clin Exp Metastasis. 2008; 2008 Jul 23. PMID: 18649116

Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, Rilling WS, Geschwind JF, Salem R, Vedantham S, Cardella JF, Soulen MC: Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2007 Dec. PMID: 18057279

Liapi E, Lee KH, Georgiades CC, Hong K, Geschwind JF: Drug-eluting particles for interventional pharmacology. Tech Vasc Interv Radiol. 2007 Dec. PMID: 18572139

Georgiades CS, Hong K, Geschwind JF, Liddell R, Syed L, Kharlip J, Arepally A: Adjunctive use of C-arm CT may eliminate technical failure in adrenal vein sampling. J Vasc Interv Radiol. 2007 Sep. PMID: 17804771

Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JF: Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. J Vasc Interv Radiol. 2007 Aug. PMID: 17675611

Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA Jr, Kulik L, Geschwind JF, Murthy R, Rilling W, Liu D, Bester L, Bilbao JI, Kennedy AS, Omary RA, Salem R: Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol. 2007 Jul-Aug; 2007 May 22. PMID: 17516113

Thorisson HM, Pollak JS, Scoutt L: The role of ultrasound in the diagnosis and treatment of chronic venous insufficiency. Ultrasound Q. 2007 Jun. PMID: 17538489

Lesnik GT, Ross DA, Henderson KJ, Joe JK, Leder SB, White RI Jr: Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation. Am J Rhinol. 2007 May-Jun. PMID: 17621815

Yiu WK, Basco MT, Aruny JE, Cheng SW, Sumpio BE: Cryosurgery: A review. Int J Angiol. 2007 Spring. PMID: 22477240

Liapi E, Geschwind JF: Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol. 2007 Mar 10. PMID: 17350947

Kobeiter H, Georgiades CS, Leakakos T, Torbenson M, Hong K, Geschwind JF: Targeted transarterial therapy of Vx-2 rabbit liver tumor with Yttrium-90 labeled ferromagnetic particles using an external magnetic field. Anticancer Res. 2007 Mar-Apr. PMID: 17465199

Liapi E, Georgiades CC, Hong K, Geschwind JF: Transcatheter arterial chemoembolization: current technique and future promise. Tech Vasc Interv Radiol. 2007 Mar. PMID: 17980314

Dorfman JD, Schulick R, Choti MA, Geschwind JF, Kamel I, Torbenson M, Thuluvath PJ: Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States. World J Gastroenterol. 2007 Feb 7. PMID: 17278203

Vali M, Liapi E, Kowalski J, Hong K, Khwaja A, Torbenson MS, Georgiades C, Geschwind JF: Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer. J Vasc Interv Radiol. 2007 Jan. PMID: 17296709

Kamel IR, Reyes DK, Liapi E, Bluemke DA, Geschwind JF: Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol. 2007 Jan. PMID: 17296704

Georgiades CS, Liapi E, Frangakis C, Park JU, Kim HW, Hong K, Geschwind JF: Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization. J Vasc Interv Radiol. 2006 Oct. PMID: 17057003

Aruny JE, Perazella MA: An odd case of hypertension. Am J Med. 2006 Sep. PMID: 16945609

Georgiades CS, Hong K, Geschwind JF: Pre- and postoperative clinical care of patients undergoing interventional oncology procedures: a comprehensive approach to preventing and mitigating complications. Tech Vasc Interv Radiol. 2006 Sep. PMID: 17561214

Hong K, Georgiades CS, Hebert J, Wahlin T, Mitchell SE, Geschwind JF: Incorporating physician assistants and physician extenders in the contemporary interventional oncology practice. Tech Vasc Interv Radiol. 2006 Sep. PMID: 17561211

Modlin IM, Latich I, Zikusoka M, Kidd M, Eick G, Chan AK: Gastrointestinal carcinoids: the evolution of diagnostic strategies. J Clin Gastroenterol. 2006 Aug. PMID: 16917396

Modlin IM, Kidd M, Latich I, Zikusoka MN, Eick GN, Mane SM, Camp RL: Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed. Ann Surg. 2006 Jul. PMID: 16794389

Hong K, Georgiades CS, Geschwind JF: Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques. Nat Clin Pract Oncol. 2006 Jun. PMID: 16757969

Dillon B, Goodman TR: A periureteric venous ring diagnosed by MRI: an unusual cause of flank pain. Pediatr Radiol. 2006 Jun; 2006 Apr 21. PMID: 16708207

Modlin IM, Latich I, Kidd M, Zikusoka M, Eick G: Therapeutic options for gastrointestinal carcinoids. Clin Gastroenterol Hepatol. 2006 May. PMID: 16630755

Hong K, Khwaja A, Liapi E, Torbenson MS, Georgiades CS, Geschwind JF: New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res. 2006 Apr 15. PMID: 16638866

Kidd M, Modlin IM, Mane SM, Camp RL, Eick GN, Latich I, Zikusoka MN: Utility of molecular genetic signatures in the delineation of gastric neoplasia. Cancer. 2006 Apr 1. PMID: 16502410

Brewster UC, Mojibian HR, Aruny JE, Perazella MA: Access stenosis and stent fracture. Am J Kidney Dis. 2006 Mar. PMID: 16493739

Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF: The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol. 2006 Mar. PMID: 16567675

Kidd M, Modlin IM, Mane SM, Camp RL, Eick G, Latich I: The role of genetic markers--NAP1L1, MAGE-D2, and MTA1--in defining small-intestinal carcinoid neoplasia. Ann Surg Oncol. 2006 Feb; 2006 Jan 20. PMID: 16424981

Brown DB, Geschwind JF, Soulen MC, Millward SF, Sacks D: Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol. 2006 Feb. PMID: 16517767

Tal MG, Peixoto AJ, Crowley ST, Denbow N, Eliseo D, Pollak J: Comparison of side hole versus non side hole high flow hemodialysis catheters. Hemodial Int. 2006 Jan. PMID: 16441829

Pollak JS, Saluja S, Thabet A, Henderson KJ, Denbow N, White RI Jr: Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations. J Vasc Interv Radiol. 2006 Jan. PMID: 16415131

Zikusoka MN, Kidd M, Eick G, Latich I, Modlin IM: The molecular genetics of gastroenteropancreatic neuroendocrine tumors. Cancer. 2005 Dec 1. PMID: 16258976

Hong K, Kobeiter H, Georgiades CS, Torbenson MS, Geschwind JF: Effects of the type of embolization particles on carboplatin concentration in liver tumors after transcatheter arterial chemoembolization in a rabbit model of liver cancer. J Vasc Interv Radiol. 2005 Dec. PMID: 16371540

Georgiades CS, Hong K, D'Angelo M, Geschwind JF: Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol. 2005 Dec. PMID: 16371532

Lewandowski RJ, Thurston KG, Goin JE, Wong CY, Gates VL, Van Buskirk M, Geschwind JF, Salem R: 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging. J Vasc Interv Radiol. 2005 Dec. PMID: 16371530

Goldberg SN, Bonn J, Dodd G, Dupuy D, Geschwind JH, Hicks M, Hume KM, Lee FT, Lewis CA, Lencioni RA, Omary RA, Rundback JH, Silverman S, Dorfman GS, Society of Interventional Radiology Interventional Oncology Task Force: Society of Interventional Radiology Interventional Oncology Task Force: interventional oncology research vision statement and critical assessment of the state of research affairs. J Vasc Interv Radiol. 2005 Oct. PMID: 16221897

Liapi E, Hong K, Georgiades CS, Geschwind JF: Three-dimensional rotational angiography: introduction of an adjunctive tool for successful transarterial chemoembolization. J Vasc Interv Radiol. 2005 Sep. PMID: 16151066

Jones E, Nafiu B, Amankwah K, Pollak JS, Gusberg RJ, Dardik A: Use of N-acetylcholine and sodium bicarbonate to protect renal transplant function during endovascular renal artery aneurysm exclusion. Vascular. 2005 Sep-Oct. PMID: 16288706

Geschwind JF, Liapi E: Is radiofrequency ablation an effective long-term treatment for early-stage hepatocellular carcinoma? Nat Clin Pract Gastroenterol Hepatol. 2005 Jul. PMID: 16265281

Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD: Current status of gastrointestinal carcinoids. Gastroenterology. 2005 May. PMID: 15887161

Burger I, Hong K, Schulick R, Georgiades C, Thuluvath P, Choti M, Kamel I, Geschwind JF: Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol. 2005 Mar. PMID: 15758131

Hong K, Liapi E, Georgiades CS, Geschwind JF: Case-controlled comparison of a percutaneous collagen arteriotomy closure device versus manual compression after liver chemoembolization. J Vasc Interv Radiol. 2005 Mar. PMID: 15758129

Rifkin BS, Brewster UC, Aruny JE, Perazella MA: Percutaneous balloon cryoplasty: a new therapy for rapidly recurrent anastomotic venous stenoses of hemodialysis grafts? Am J Kidney Dis. 2005 Feb. PMID: 15685498

Proctor DD, Henderson KJ, Dziura JD, Longacre AV, White RI Jr: Enteroscopic evaluation of the gastrointestinal tract in symptomatic patients with hereditary hemorrhagic telangiectasia. J Clin Gastroenterol. 2005 Feb. PMID: 15681905

Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K: Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol. 2005 Feb. PMID: 15713921

Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K: Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol. 2005 Feb. PMID: 15713920

Hindley J, Gedroyc WM, Regan L, Stewart E, Tempany C, Hynyen K, Mcdannold N, Inbar Y, Itzchak Y, Rabinovici J, Kim HS, Geschwind JF, Hesley G, Gostout B, Ehrenstein T, Hengst S, Sklair-Levy M, Shushan A, Jolesz F: MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol. 2004 Dec. PMID: 15547216

Geschwind JF, Salem R, Carr BI, Soulen MC, Thurston KG, Goin KA, Van Buskirk M, Roberts CA, Goin JE: Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology. 2004 Nov. PMID: 15508085

Agrawal N, Bettegowda C, Cheong I, Geschwind JF, Drake CG, Hipkiss EL, Tatsumi M, Dang LH, Diaz LA Jr, Pomper M, Abusedera M, Wahl RL, Kinzler KW, Zhou S, Huso DL, Vogelstein B: Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A. 2004 Oct 19; 2004 Oct 7. PMID: 15471990

Geschwind JF, Georgiades CS, Ko YH, Pedersen PL: Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma. Expert Rev Anticancer Ther. 2004 Jun. PMID: 15161443

Yoo HY, Patt CH, Geschwind JF, Thuluvath PJ: The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol. 2003 Dec 1; 2003 Oct 27. PMID: 14581446

Arleo EK, Pollak J, Tal MG: Changing trends in gynecologists' opinions of uterine artery embolization for fibroids: the patient's perspective. J Vasc Interv Radiol. 2003 Dec. PMID: 14654491

Hoeben H, Abu-Alfa AK, Reilly RF, Aruny JE, Bouman K, Perazella MA: Vascular access surveillance: evaluation of combining dynamic venous pressure and vascular access blood flow measurements. Am J Nephrol. 2003 Nov-Dec; 2003 Oct 17. PMID: 14566106

Ornan D, White R, Pollak J, Tal M: Pelvic embolization for intractable postpartum hemorrhage: long-term follow-up and implications for fertility. Obstet Gynecol. 2003 Nov. PMID: 14672461

Tatsumi M, Nakamoto Y, Traughber B, Marshall LT, Geschwind JF, Wahl RL: Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose. Cancer Res. 2003 Oct 1. PMID: 14559811

Kamel IR, Bluemke DA, Ramsey D, Abusedera M, Torbenson M, Eng J, Szarf G, Geschwind JF: Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol. 2003 Sep. PMID: 12933464

Bochenek KM, Aruny JE, Tal MG: Right atrial migration and percutaneous retrieval of a Günther Tulip inferior vena cava filter. J Vasc Interv Radiol. 2003 Sep. PMID: 14514816

Geschwind JF, Ramsey DE, Choti MA, Thuluvath PJ, Huncharek MS: Chemoembolization of hepatocellular carcinoma: results of a metaanalysis. Am J Clin Oncol. 2003 Aug. PMID: 12902882

Geschwind JF, Dagli MS, Lambert DL, Kobeiter H: Thrombolytic therapy in the setting of arterial line-induced ischemia. J Endovasc Ther. 2003 Jun. PMID: 12932173

Udelsman R, Aruny JE, Donovan PI, Sokoll LJ, Santos F, Donabedian R, Venbrux AC: Rapid parathyroid hormone analysis during venous localization. Ann Surg. 2003 May. PMID: 12724638

Mudrick D, Arepally A, Geschwind JF, Ronsivalle JA, Lund GB, Scheel P: Spontaneous renal artery dissection: treatment with coil embolization. J Vasc Interv Radiol. 2003 Apr. PMID: 12682209

Geschwind JF, Ramsey DE, Cleffken B, van der Wal BC, Kobeiter H, Juluru K, Hartnell GG, Choti MA: Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency. Cardiovasc Intervent Radiol. 2003 Mar-Apr; 2003 Mar 6. PMID: 12616414

Geschwind JF, Dagli MS, Vogel-Claussen J, Seifter E, Huncharek MS: Metastatic breast carcinoma presenting as a large pulmonary embolus: case report and review of the literature. Am J Clin Oncol. 2003 Feb. PMID: 12576931

McCarthy DM, Haas M, Thuluvath PJ, Geschwind JF, Hutchins GM, Westra WH: Pulmonary embolization of bovine collagen. Arch Pathol Lab Med. 2003 Feb. PMID: 12562255

Longacre AV, Gross CP, Gallitelli M, Henderson KJ, White RI Jr, Proctor DD: Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol. 2003 Jan. PMID: 12526937

Koniaris LG, Seibel JA, Geschwind JF, Sitzmann JV: Can ethanol therapies injure the bile ducts? Hepatogastroenterology. 2003 Jan-Feb. PMID: 12629993

Tal MG, Saluja S, Henderson KJ, White RI Jr: Vein of Galen technique for occluding the aneurysmal sac of pulmonary arteriovenous malformations. J Vasc Interv Radiol. 2002 Dec. PMID: 12471191

Geschwind JF, Kaushik S, Ramsey DE, Choti MA, Fishman EK, Kobeiter H: Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol. 2002 Nov. PMID: 12427817

Geschwind JF: Chemoembolization for hepatocellular carcinoma: where does the truth lie? J Vasc Interv Radiol. 2002 Oct. PMID: 12397119

Ramsey DE, Geschwind JF: New interventions for liver tumors. Semin Roentgenol. 2002 Oct. PMID: 12455128

Salem R, Thurston KG, Carr BI, Goin JE, Geschwind JF: Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol. 2002 Sep. PMID: 12354840

Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF: Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol. 2002 Sep. PMID: 12354839

Geschwind JF, Rilling WS: Hepatocellular carcinoma: obligation and opportunity for interventional radiology. J Vasc Interv Radiol. 2002 Sep. PMID: 12354832

Ramsey DE, Geschwind JF: Chemoembolization of hepatocellular carcinoma--what to tell the skeptics: review and meta-analysis. Tech Vasc Interv Radiol. 2002 Sep. PMID: 12524642

Geschwind JF, Ko YH, Torbenson MS, Magee C, Pedersen PL: Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res. 2002 Jul 15. PMID: 12124317

Geschwind JF, Degli MS, Morris JM, Choti MA: Re: Treatment of focal nodular hyperplasia with selective transcatheter arterial embolization using iodized oil and polyvinyl alcohol. Cardiovasc Intervent Radiol. 2002 Jul-Aug; 2002 Jun 20. PMID: 12324823

Pollak JS: Malignant pleural effusions: treatment with tunneled long-term drainage catheters. Curr Opin Pulm Med. 2002 Jul. PMID: 12055393

Georgiades CS, Geschwind JF: Percutaneous peritoneal dialysis catheter placement for the management of end-stage renal disease: technique and comparison with the surgical approach. Tech Vasc Interv Radiol. 2002 Jun. PMID: 12489049

Geschwind JF, Dagli MS, Vogel-Claussen J, Arepally AA, Venbrux AC: Percutaneous removal of a fractured endostent remnant from the portal vein. Cardiovasc Intervent Radiol. 2002 Mar-Apr; 2002 Feb 19. PMID: 11901437